LumiGene Inks Reverse Acquisition Pact with Pole Perfect; Dances into Public Market | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – LumiGene today announced it has signed a letter of intent to be acquired by dance studio Pole Perfect Studios in a reverse acquisition that will take LumiGene public.

Upon completion of the deal, LumiGene will become the primary focus of the combined company.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.